DD283619A5 - Verfahren zur herstellung neuer 3,4,5-substituierter 4h-1,2,4-triazole - Google Patents

Verfahren zur herstellung neuer 3,4,5-substituierter 4h-1,2,4-triazole Download PDF

Info

Publication number
DD283619A5
DD283619A5 DD89326479A DD32647989A DD283619A5 DD 283619 A5 DD283619 A5 DD 283619A5 DD 89326479 A DD89326479 A DD 89326479A DD 32647989 A DD32647989 A DD 32647989A DD 283619 A5 DD283619 A5 DD 283619A5
Authority
DD
German Democratic Republic
Prior art keywords
alkyl
formula
compounds
fused
och
Prior art date
Application number
DD89326479A
Other languages
German (de)
English (en)
Inventor
Kurt Schromm
Gerhard Walther
Herbert Heuer
Gojko Muacevic
Franz Birke
Original Assignee
�������@������������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������������@��k�� filed Critical �������@������������@��k��
Publication of DD283619A5 publication Critical patent/DD283619A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD89326479A 1988-03-12 1989-03-10 Verfahren zur herstellung neuer 3,4,5-substituierter 4h-1,2,4-triazole DD283619A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3808283A DE3808283A1 (de) 1988-03-12 1988-03-12 Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD283619A5 true DD283619A5 (de) 1990-10-17

Family

ID=6349565

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89326479A DD283619A5 (de) 1988-03-12 1989-03-10 Verfahren zur herstellung neuer 3,4,5-substituierter 4h-1,2,4-triazole

Country Status (14)

Country Link
EP (1) EP0335144A1 (xx)
JP (1) JPH01275571A (xx)
KR (1) KR890014525A (xx)
AU (1) AU3119089A (xx)
DD (1) DD283619A5 (xx)
DE (1) DE3808283A1 (xx)
DK (1) DK117089A (xx)
FI (1) FI891153A (xx)
HU (1) HUT51615A (xx)
IL (1) IL89571A0 (xx)
NO (1) NO891046L (xx)
PT (1) PT89977A (xx)
YU (1) YU50689A (xx)
ZA (1) ZA891799B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002731A1 (de) * 1989-08-19 1991-03-07 Boehringer Ingelheim Kg Substituierte n-heterocyclen, ihre herstellung und verwendung
AU2000223275A1 (en) * 2000-02-08 2001-08-20 Yamanouchi Pharmaceutical Co..Ltd. Novel triazole derivatives
JP3873746B2 (ja) * 2000-05-19 2007-01-24 アステラス製薬株式会社 トリアゾール誘導体
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
US11555031B2 (en) 2017-03-20 2023-01-17 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
CN110467579B (zh) * 2019-07-30 2020-08-25 浙江理工大学 一种5-三氟甲基取代的1,2,4-三氮唑化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1378617A (en) * 1972-05-05 1974-12-27 Upjohn Co Triazolylbenzophenones
FR2269938A2 (en) * 1974-05-08 1975-12-05 Delalande Sa 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2539127B1 (fr) * 1983-01-10 1985-08-23 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicaments
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines

Also Published As

Publication number Publication date
ZA891799B (en) 1990-11-28
PT89977A (pt) 1989-11-10
KR890014525A (ko) 1989-10-24
AU3119089A (en) 1989-09-14
YU50689A (en) 1991-04-30
FI891153A0 (fi) 1989-03-10
DK117089D0 (da) 1989-03-10
IL89571A0 (en) 1989-09-10
FI891153A (fi) 1989-09-13
DK117089A (da) 1989-09-13
HUT51615A (en) 1990-05-28
EP0335144A1 (de) 1989-10-04
NO891046D0 (no) 1989-03-10
JPH01275571A (ja) 1989-11-06
NO891046L (no) 1989-09-13
DE3808283A1 (de) 1989-09-21

Similar Documents

Publication Publication Date Title
EP0175363B1 (de) 4, 5-Dihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und ihre Verwendung
DE68926976T2 (de) Kondensierte polyzyklische Verbindungen, Zusammenstellungen, Verfahren zur Herstellung und deren Anwendung als PAF-antagonistische, antihistaminische und/oder anti-inflammatorische Agenzien
CH624395A5 (xx)
DE1920037A1 (de) Neue 1,2,4-Oxadiazol-Derivate und Verfahren zur Herstellung derselben
DD201589A5 (de) Verfahren zur herstellung von aminothiadiazolen
DD211340A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
EP0116708B1 (de) Neue substituierte 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3522579C2 (de) Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben
EP0335381A1 (de) Neue 2,3,4-substituierte Imidazole und 3,4,5-substituierte 1,2,4-Triazole, ihre Herstellung und Verwendung
CH645892A5 (de) Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel.
DD283619A5 (de) Verfahren zur herstellung neuer 3,4,5-substituierter 4h-1,2,4-triazole
WO1996002505A1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
DD206994A5 (de) Verfahren zur herstellung von pyridinderivaten
DE3900028A1 (de) Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE2522143A1 (de) 3-(4-acylaminopiperazin-1-yl-alkyl)- indole und verfahren zu ihrer herstellung
EP0253084A2 (de) 1,3-Disubstituierte Imidazoliumsalze
DE2717415A1 (de) Verfahren zur herstellung von phenylpiperazinderivaten, phenylpiperazinderivate und diese enthaltende pharmazeutische zubereitungen
DE68913167T2 (de) Indol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE2526467A1 (de) 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE69005833T2 (de) Entzündungshemmende 1-Heteroaryloxindole-3-Carboxamide.
WO1991002731A1 (de) Substituierte n-heterocyclen, ihre herstellung und verwendung
DE3913597A1 (de) Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0197189A2 (de) 1,3,4-Thiadiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0575754A1 (de) Pyridyl-1,2,5-oxadiazol-carbonamid-2-oxide zur Behandlung von NO-abhängigen dysfunktionen, wie Angina Pectoris und Erektionsstörungen
AT376973B (de) Verfahren zum herstellen neuer carbostyrilderivate und von saeureadditionssalzen und quaternaeren salzen hievon und ihren optischen isomeren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee